Autoimmunity aids survival in melanoma.
Senior
Kathryn
K
D000970:Antineoplastic Agents / Q000627:therapeutic use; D015551:Autoimmunity; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008545:Melanoma / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology*; D011379:Prognosis; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology*; D016019:Survival Analysis
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins